ArticleThyroid : official journal of the American Thyroid Association2024
Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study.
Open access · greenAbstract readMulticenter Study
In one paragraph
Article in Thyroid : official journal of the American Thyroid Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 39 citations in OpenAlex.
- RET p.Cys634-driven progression of hereditary vs. sporadic medullary thyroid cancer.Endocrine · 2026Article
- Somatic genomic profiling reveals clinically relevant heterogeneity inJournal of clinical & translational endocrinology · 2026Article
- Metastatic Medullary Thyroid Carcinoma Without Identifiable Primary Tumor Within the Thyroid Gland, Presenting with Initial Lymph Node Metastasis Followed by Distant Peritoneal Metastasis: A Case Report of a Rare Phenomenon.Journal of clinical medicine · 2026Article
- Prediction of distant metastases at diagnosis in medullary thyroid cancer: combining calcitonin with lymph node imaging.Journal of the Endocrine Society · 2026Article
- Multi-center multi-omics integration predicts individualized prognosis in medullary thyroid carcinoma.Nature communications · 2026Article
- How to manage medullary thyroid carcinoma: current treatment strategies.Drugs in context · 2026Review
- Machine-learning prediction of 3- and 5-year mortality in lymph-node-positive medullary thyroid carcinoma: a study based on the SEER database and external validation in a Chinese cohort.Frontiers in oncology · 2026Article
- Multi-center Assessment of DLL3 Expression by Immunohistochemistry in Medullary Thyroid Carcinoma.Endocrine pathology · 2025Article
- Somatic genetic alterations in the development and progression in thyroid tumors of follicular cells.European thyroid journal · 2025Review
- Overlapping Presentations and Diverse Genetic Defects Characterize Neuroendocrine Neoplasms in a Mexican Cohort.The Journal of clinical endocrinology and metabolism · 2025Article
- Detection of SEZ6, a Therapeutic Target, in Medullary Thyroid Carcinoma.The Journal of clinical endocrinology and metabolism · 2025Article
- Article
- An Analysis of Primary Hyperparathyroidism in Individuals Diagnosed with Multiple Endocrine Neoplasia Type 2.Diseases (Basel, Switzerland) · 2025Review
- Mechanisms of resistance to RET-directed therapies.Endocrine-related cancer · 2025Review
- Systemic Therapies for Advanced Medullary Thyroid Carcinoma.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer · 2025Review
- Minor role of TP53 and TERT promoter mutations in medullary thyroid carcinoma: report of new cases and revision of the literature.Endocrine · 2025Review
- Surgical Treatment of Medullary Thyroid Cancer.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer · 2025Review
- Hydrogel-driven innovations for targeted delivery, immune modulation, and tissue repair in thyroid cancer therapy.Frontiers in cell and developmental biology · 2025Review
- The Potential Utility of RAS Q61R Immunohistochemistry as a Screening Tool in Pre-operative Fine Needle Aspirates of Medullary Thyroid Carcinoma.Endocrine pathology · 2024Article
- Distinct Impacts of Clinicopathological and Mutational Profiles on Long-Term Survival and Recurrence in Medullary Thyroid Carcinoma.Endocrinology and metabolism (Seoul, Korea) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
46 authors at 10 institutions in 4 countries.
Bin XuDepartment of Pathology and Laboratory Medicine; New York, New York, USA.ORCID 0000-0003-4638-9835
Kartik ViswanathanDepartment of Pathology, Emory University Hospital Midtown, Atlanta, Georgia, USA.ORCID 0000-0003-0031-0001
Mahsa S AhadiRoyal North Shore Hospital and Northern Clinical School, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
Sara AhmadiDivision of Endocrinology and Metabolism, Department of Medicine; Boston, Harvard Medical School, Boston, Massachusetts, USA.
Bayan AlzumailiDepartment of Pathology and Laboratory Medicine; New York, New York, USA.
Mohamed-Amine BaniMedical Pathology and Biology Department; Service d'oncologie endocrinienne; Gustave Roussy Campus Cancer, Villejuif, France.
Eric BaudinDépartement d'imagerie, Service d'oncologie endocrinienne; Gustave Roussy Campus Cancer, Villejuif, France.
David Blake BehrmanDepartment of Pathology, Emory University Hospital Midtown, Atlanta, Georgia, USA.
Marzia CapellettiDepartment of Pathology; Brigham and Women's Hospital, Boston, Harvard Medical School, Boston, Massachusetts, USA.
Nicole G ChauDepartment of Pathology; Brigham and Women's Hospital, Boston, Harvard Medical School, Boston, Massachusetts, USA.
Federico ChiarucciDepartment of Medical and Surgical Sciences (DIMEC), University of Bologna Medical Center; Bologna, Italy.ORCID 0000-0002-7483-0336
Angela ChouRoyal North Shore Hospital and Northern Clinical School, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
Roderick Clifton-BlighRoyal North Shore Hospital and Northern Clinical School, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
Sara ColuccelliDepartment of Medical and Surgical Sciences (DIMEC), University of Bologna Medical Center; Bologna, Italy.
Dario de BiaseDepartment of Pharmacy and Biotechnology; Bologna, Italy.
Antonio De LeoDepartment of Medical and Surgical Sciences (DIMEC), University of Bologna Medical Center; Bologna, Italy.ORCID 0000-0002-3761-5135
Snjezana DoganDepartment of Pathology and Laboratory Medicine; New York, New York, USA.
James A FaginDivision of Specialized Medicine; New York, New York, USA.ORCID 0000-0002-2365-2517
Talia L FuchsRoyal North Shore Hospital and Northern Clinical School, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
Anthony Robert GloverRoyal North Shore Hospital and Northern Clinical School, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0003-0762-0977
Julien HadouxDépartement d'imagerie, Service d'oncologie endocrinienne; Gustave Roussy Campus Cancer, Villejuif, France.ORCID 0000-0002-1276-3289
Ludovic LacroixMedical Pathology and Biology Department; Service d'oncologie endocrinienne; Gustave Roussy Campus Cancer, Villejuif, France.
Livia LamartinaDépartement d'imagerie, Service d'oncologie endocrinienne; Gustave Roussy Campus Cancer, Villejuif, France.
Daniel J LubinDepartment of Pathology, Emory University Hospital Midtown, Atlanta, Georgia, USA.
Catherine LuxfordRoyal North Shore Hospital and Northern Clinical School, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
Kelly MaglioccaDepartment of Pathology, Emory University Hospital Midtown, Atlanta, Georgia, USA.
Thais MalobertiDepartment of Medical and Surgical Sciences (DIMEC), University of Bologna Medical Center; Bologna, Italy.
Abhinita S MohantyDepartment of Pathology and Laboratory Medicine; New York, New York, USA.
Fedaa NajdawiDepartment of Pathology; Brigham and Women's Hospital, Boston, Harvard Medical School, Boston, Massachusetts, USA.
Aradhya NigamDepartment of Surgery; Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Alexander James PapachristosRoyal North Shore Hospital and Northern Clinical School, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
Andrea RepaciDivision of Endocrinology and Diabetes Prevention and Care; IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.
Bruce RobinsonRoyal North Shore Hospital and Northern Clinical School, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
Jean-Yves ScoazecMedical Pathology and Biology Department; Service d'oncologie endocrinienne; Gustave Roussy Campus Cancer, Villejuif, France.
Qiuying ShiDepartment of Pathology, Emory University Hospital Midtown, Atlanta, Georgia, USA.
Stan SidhuRoyal North Shore Hospital and Northern Clinical School, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
Erica SolaroliEndocrinology Unit, Azienda USL di Bologna, Bologna, Italy.
Mark SywakRoyal North Shore Hospital and Northern Clinical School, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
R Michael TuttleDivision of Specialized Medicine; New York, New York, USA.
Brian UntchDepartment of Surgery; Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Justine A BarlettaDepartment of Pathology; Brigham and Women's Hospital, Boston, Harvard Medical School, Boston, Massachusetts, USA.
Abir Al GhuzlanMedical Pathology and Biology Department; Service d'oncologie endocrinienne; Gustave Roussy Campus Cancer, Villejuif, France.
Anthony J GillRoyal North Shore Hospital and Northern Clinical School, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
Ronald GhosseinDepartment of Pathology and Laboratory Medicine; New York, New York, USA.
Giovanni TalliniDepartment of Medical and Surgical Sciences (DIMEC), University of Bologna Medical Center; Bologna, Italy.
Ian GanlyDepartment of Surgery; Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Royal North Shore Hospital · AUInstitut Gustave Roussy · FRUniversity of Bologna · ITEmory University Hospital Midtown · USNew York University · USBrigham and Women's Hospital · USMemorial Sloan Kettering Cancer Center · USAzienda USL di Bologna · ITSpecialized Dentistry of New York · USBoston Medical Center · US
Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4MNCI NIH HHS P30 CA008748
Abstract
PubMed holds no abstract for this paper.
Indexed as
Carcinoma, NeuroendocrineThyroid NeoplasmsGenomicsHumansMaleMutationProto-Oncogene Proteins c-retRetrospective StudiesProto-Oncogene Proteins c-retgrademedullary thyroid carcinomaprognosisRASRET
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.